• Bhubaneswar India
  • Contact+ 91-9938772605
  • Mon - Sat : 10:00AM - 6:00PM

Tag: Mankind Pharma’

Mankind Pharma Unveils Nimulid Strong for Neck Pain in Growing Analgesic Market

Mumbai, September 2, 2024: Mankind Pharma, one of India’s leading pharmaceutical companies has announced its entry into the topical analgesic market through its consumer business division. The company is introducing Nimulid Strong, a revolutionary gel and spray formulation specifically designed to address neck pain, a condition that significantly impacts overall body function.

Nimulid Strong boasts a unique selling proposition of containing 2X diclofenac concentration, promising faster relief for consumers suffering from neck pain. This strategic move is in alignment with Mankind Pharma’s commitment to expanding its consumer healthcare portfolio and addressing critical pain management needs.

The launch is accompanied by a compelling video campaign titled #GardanHilaateRaho that highlights the cultural significance of neck movements in Indian communication. The campaign, voiced in Hindi, intertwines the importance of unrestricted neck movement with the efficacy of Nimulid Strong in alleviating neck pain. Therefore, to address the problem, the brand came up with a powerful campaign of Nimulid Strong that focuses on “Kaam Chalate Raho, Gardan Hilaate Raho.”

The video narrative ingeniously connects various scenarios where neck movements play a crucial role in non-verbal communication, from expressing anger and love to showcasing progress and even celebrating national victories. It emphasises how Nimulid Strong, with its powerful 2X diclofenac formulation, ensures that neck pain doesn’t hinder these essential interactions.

Joy Chatterjee, Vice President, Sales and Marketing Head, Consumer Business Unit, Mankind Pharma Ltd, shared, “Our entry into the topical analgesic market with Nimulid Strong marks a pivotal moment for Mankind Pharma’s consumer business. By focusing on neck pain, which can severely hinder daily life, we aim to empower millions of Indians to live and communicate more freely. Our innovative 2X diclofenac formulation, paired with a resonant video campaign, showcases how integral neck movements are in daily interactions. The campaign’s message, ‘Gardan dard ka specialist’ (Specialist in neck pain), positions Nimulid Strong as the go-to solution for this specific, yet widespread problem.”

Nimulid Strong will be available in both gel and spray variants, offering consumers flexibility in application. The product is set to be distributed across pharmacies and modern trade outlets nationwide, supported by an extensive marketing campaign across various media platforms.

With the topical analgesic market in India valued at ₹1488 crore, according to IQVIA, Mankind Pharma’s launch of Nimulid Strong arrives at a pivotal moment. This strategic move aligns with the company’s commitment to delivering high-quality, affordable healthcare solutions. By focusing on specific pain management needs, Nimulid Strong represents a significant advancement in Mankind Pharma’s consumer healthcare segment, positioning the company to capture a substantial share of the expanding market through its established distribution network and strong brand reputation.

Mankind Pharma Signs Non-Exclusive Patent License Agreement with Takeda to Commercialize Vonoprazan in India

Mumbai, July 16, 2024: Mankind Pharma Limited and Takeda Pharmaceutical Company Limited signed a Non-Exclusive Patent License Agreement for commercialising ‘Vonoprazan’ in the Indian market. The agreement allows Mankind Pharma to launch the novel drug for treating Gastroesophageal Reflux Disease (GERD) under its trademark.

Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders, including Gastroesophageal Reflux Disease (GERD). The drug is effective in treating conditions such as erosive oesophagitis, gastric ulcer, duodenal ulcer, peptic ulcer, gastro-oesophageal reflux, reflux oesophagitis, and Helicobacter pylori eradication.

Mr. M Ramesh, EVP – Global Business Development – Mankind Pharma Limited, said, “This non-exclusive patent license agreement with Takeda aligns with our commitment to bringing innovative and effective treatments to patients in India. By introducing Vonoprazan, we aim to address a significant medical need and improve the quality of life for those suffering from acid-related illnesses with a new and advanced option for managing acid-related disorders, potentially offering improved health outcomes and quality of life.”

Mankind Pharma Sparks RippleOfChange Campaign with Multi-City Blood Donation Drive

National, June 13, 2024: Mankind Pharma, a globally renowned pharmaceutical company, has launched a major multi-city campaign titled #RippleOfChange on World Blood Donor Day. This initiative aims to address the critical shortage of blood donors in India and raise awareness about the importance of blood donation.

Blood Donor Day 2

The campaign’s centrepiece is a powerful video that portrays the dire consequences of blood scarcity. The narrative follows a group of friends who experience the tragic loss of a loved one due to the unavailability of blood donors. The video aims to inspire more people to donate by highlighting how a simple act can save precious lives.

“With less than 1% of our population donating blood annually, India faces a severe and ongoing blood shortage crisis,” said Mr. Rajeev Juneja, Vice-Chairman and Managing Director, Mankind Pharma Ltd. “This critical shortfall in blood donations leads to the preventable loss of thousands of lives every day. Kindness resides in all of us, yet while many discuss this issue, few step forward to donate. Our #RippleOfChange movement aims to transform this notion by inspiring individuals to take action. By donating blood, each person can contribute to a ripple effect of positive change, saving lives, supporting medical emergencies, and fostering a culture of community care and responsibility.”

The integrated campaign spans digital, outdoor and on-ground activations across multiple cities. It features the release of the #RippleOfChange video on various digital platforms. Metro trains will feature innovative mirror installations to encourage commuters to reflect on becoming blood donors. Bus shelter ads in Delhi will further amplify the call to action. Additionally, Mankind Pharma is organizing free blood donation camps at its offices in Paonta Sahib, Manesar, and Delhi’s Okhla head office with 600+ people enrolled to date for this cause.

Despite India’s large population, the country faces an annual blood shortage of a million units annually, according to industry reports. This lack of access to blood costs over 12,000 lives every day. At Mankind Pharma, we believe that saving someone’s life is one of the noblest acts one can perform, deserving active support rather than passive discussion. The company’s employees, known as Mankindians, regularly donate blood and advocate for this cause, demonstrating the potential for collective action to create a significant positive impact.

Social Beat Wins Digital D2C Mandate for Mankind Pharma

Leading digital marketing agency, Social Beat, has secured the D2C digital mandate for Mankind Pharma, one of India’s leading pharmaceutical companies after a multi-agency pitch. The partnership with Social Beat will mark a significant step forward in Mankind Pharma’s digital marketing efforts to strengthen its online presence and engage with a wider audience.

Mankind Pharma, known for its commitment to providing high-quality healthcare solutions, has chosen Social Beat as its digital partner to drive sales through the brand’s own website and drive growth in the digital space. With a diverse portfolio of pharmaceutical products, Mankind Pharma aims to connect with consumers across various demographics and geographies.

“We are delighted to be chosen as the digital marketing partner for Mankind Pharma,” said Suneil Chawla, Co-founder of Social Beat. “This collaboration presents a fantastic opportunity to leverage our expertise in digital marketing to help Mankind Pharma reach new heights in the online landscape. We look forward to crafting a highly impactful website and campaigns that resonate with Mankind Pharma’s objectives and growth.”

Social Beat, known for its data-driven approach and creative digital solutions, has a track record of delivering outstanding results for a wide range of clients across industries. The agency will be responsible for crafting and executing comprehensive digital marketing strategies for Mankind Pharma, encompassing various channels such as social media, search engine optimization (SEO), content marketing, and more.

Mr.Joy Chatterjee - Associate Vice President, Mankind

Speaking about the partnership, Mr Joy Chatterjee, AVP at Mankind Pharma, said, “In today’s digital age, it is imperative for us to have a strong online presence and engage effectively with our customers. Social Beat’s expertise in the digital marketing arena and their proven track record make them the ideal partner for our digital journey. We are excited about the opportunities this collaboration will bring and are confident that together, we will achieve great success.”

Social Beat’s experience in the pharmaceutical sector, coupled with its understanding of the Indian market, positions it well to assist Mankind Pharma in achieving its digital marketing objectives.

What’s triggering such an impressive growth in the powdered antacids market?

Joy Chatterjee, General Manager, Sales & Marketing, Mankind Pharma

By – Joy Chatterjee, General Manager, Sales & Marketing, Mankind Pharma

One may not acknowledge gut-related discomforts as often as others, but we all will agree that it can immensely impact our day-to-day activities and leave a lingering sense of uneasiness throughout the day. Talking of gut-related health issues in the Indian context, the incidence of acidity, gas, and indigestion are the top problems that come to mind . and it has also come to light, that in recent times, the sensation of bloating, gaseousness, acidity, acid reflux & heartburn have increased considerably across all age groups & demography.

The root cause for our deteriorating gut health can be attributed to the sedentary lifestyle of the general population; this along with unhealthy eating habits, erratic sleeping cycles & insufficient water intake, consistently puts too much pressure on the digestive system, which eventually leads to some of the other gut-related chronic disorder.

Thus the persistent occurrences of acidity, gas & indigestion in peoples’ regular life, calls for an easy solution that can provide quick relief on the go. Antacids perfectly fill this demand gap. It suits the consumers & fits into their pace of life; especially powdered antacids, which have been widely accepted as an easy, convenient one-stop solution to all gut-related problems. Additionally, the growing geriatric population is inherently impacted by gastrointestinal problems too.

Therefore this category has slowly evolved into an absolute necessity in every other household thereby providing the desired demand push that has led to the growth of the OTC antacids market and will continue to do so on a larger scale throughout 2022-2031.

Interestingly, amongst all the gut health countering life choices made by antacid consumers, there is also a growing rise in awareness & collective consciousness about what people consume. While seeking instant relief from increased acidity levels causing gastroesophageal reflux sickness, consumers nowadays are more receptive to a natural/ ayurvedic remedy over others. Hence, even though the majority of the brands in the category resort to artificial/ synthetic flavouring, antacids with natural ingredients are now strongly gaining momentum. To meet this evolving preference of the consumers, the antacids market not only offers acid neutralizers which treat a wide range of problems from neutralizing stomach acid, to treating acid flux, curing heartburn, and indigestion but also caters to the demand of going with natural ingredients through Mankind Pharma’s antacid brand Gas-O-Fast, having real Jeera and Ajwain, which is taking care of all the regular gut issues like acidity, heartburn, gas, ingestion and become India ke Acidity ka Indian Solution.

Lastly, the upward swing of the powdered antacids market is further strengthened with the strong & steady emergence of the category in all major e-commerce platforms. This too has provided the category with an incremental push, driving towards the open headspace for further growth.

Mankind Pharma continues to serve life through an unparalleled spirit of collaboration to fight Covid-19

Mankind-Pharma

New Delhi, 24th January 2022: The onset of SARS-CoV-2 in late 2019 has affected millions of lives across the globe. Since the beginning of the year, India has observed a sharp rise in Covid-19 infection cases. India is grappling with the third wave of the pandemic. The surge in cases comes with the spread of the new Omicron variant, more transmissible than the Delta variant, which had triggered the second wave. As per reports, In the week ending January 9, India recorded 6,38,872 cases of Covid-19. A significant increase of more than six times – from 1,02,330 cases recorded between December 27 and January 2.

The number of active cases has grown multi-fold as the new wave of the pandemic gripped the nation. The situation over the past two and a half years has created a shock and awe among all. Undoubtedly, it has put a toll on the health infrastructure. This has led healthcare companies to come up with disruptive innovations in the field of pharmacy.

Mankind Pharma, the 4th largest pharmaceutical company in India (As per IQVIA) has been continuously increasing its efforts to contribute to people’s health and wellbeing through various initiatives. In the past two years, the company has launched several products to fight the pandemic and help people throughout the country.

The company continues to thrive on its foundational core, ‘Commitment to serving life’. The company launched a new brand SafeKind with two products —N95 Masks and hand Sanitizer to fight the disease. The mask has been carefully designed to ensure people’s safety while considering the comfort too. The Safekind face mask has a ProGuard 5 layer protection technology that filters out at least 95% of harmful bacteria. As suggested by doctors, N95 masks provide the most effective and comprehensive protection against COVID-19.

The pharma company launched a drug, ‘Betakind’ with the potential to fight COVID-19 and other respiratory viral infections. The Betakind Gargle is used as a mouthwash to kill germs that cause infections of the mouth. It also relieves dryness of the mouth and sore throat. It also expanded its OTC range of products by launching ‘Health OK’, a multivitamin and minerals tablet, which helps in maintaining energy and also assists in improving overall health and building immunity.

The foremost reason behind launching these products is that there is no shortage of products in the market, and people can avail themselves at affordable prices.

The company time to time has also rendered financial aid to citizens around the nation, who all carried out relief work to help out their community amidst the pandemic.

Speaking on the initiatives, Joy Chatterjee, General Manager- sales & marketing, Mankind Pharma, said, “Covid-19 pandemic has been a testing

Mr. Joy Chatterjee

Debunking the myths around Emergency Contraceptive Pills

By  – Joy Chatterjee, General Manager, Sales & Marketing, Mankind Pharma

Emergency Contraceptive Pills come to one’s rescue in effectively preventing unwanted pregnancy due to unprotected sex or cases when there is a contraceptive failure. It can be taken post-coitus to inhibit the process of fertilization. But according to WHO there is not much widespread use of ECP due to its lack of knowledge and where there is knowledge about ECP, people are not willing to use it because of the misconceptions looming around one’s fertility and safety.

Let’s debunk some of the common myths about Emergency Contraceptive Pills.

  • Myth – ECP cannot be purchased without Doctor’s Prescription     

Fact – Many are of the notion that buying ECP requires a valid prescription from a doctor. But on the contrary Emergency Contraceptive Pills can be easily bought over the counter from pharmacies, contraceptive clinics, hospitals, gynaecological and GP clinics without presenting any prescription or ID card.

  • Myth – Emergency Contraceptive Pills will not work after 24 hours

 Fact – As ECPs are also referred to as ‘morning-after pill,’ many believe that ECP should be taken the very next morning or in the worst case before the completion of 24 hours after having unprotected sex. Though it works best when taken at the earliest, it does not mean that it is a waste if taken post 24 hours. ECP’s work effectively for up to 3 days i.e. 72 hours after encountering unprotected sex and there are also some ECP’s that are valid for 5 days (120 hours) from the day of sex.

  • Myth – Taking pills more than once in a cycle can be dangerous and also lead to infertility

 Fact – Taking pills more than once in a cycle is not at all dangerous and is safe. Being exposed to high levels of hormones in Emergency Contraceptive Pills can disrupt the menstrual cycle, cause breast tenderness, stomach pain, nausea, vomiting, headache, tiredness but it will not lead to infertility or any serious health implications. But it must be noted that ECPs are not a regular form of contraception and other options must be considered if one is looking for prolonged contraception.   

  •  Myth – Emergency Contraceptive Pills are 100% effective

 Fact – One might think that taking ECP after coitus can successfully prevent pregnancy, but it is not always the case. There are various factors to be taken into account which ensure the effectiveness of the pills. The sooner the ECP is taken, the higher the chances of its 100% effectiveness. If taken in the later phase when ovulation has already taken place, then the functioning of ECP might be diluted. Also, if one is seeking other medication to cure illnesses like epilepsy, heartburn, etc. even then the benefits of ECP cannot be availed to the fullest.

  • Myth – ECP causes abortion

 Fact – ECP prevents pregnancy and does not end the pregnancy. It inhibits the fertilization of an egg either by stopping the release of the egg from the ovary or by preventing the implantation of the fertilized egg to the uterus. The pills work only when taken before pregnancy is established. If taken after the pregnancy, it does not have any effect on the existing pregnancy and does not harm the developing child.

 

 

gas o fast

Gas-O-Fast strengthens its digital presence with a new campaign and messaging in the industry

Mankind Pharma’s ayurvedic antacid brand Gas-O-Fast sachets have rolled out a new campaign with content creators and food bloggers. Through this campaign, the brand tries to create awareness in the social media genre as maximum audiences rely on the content creators and bloggers.

Over the years, the brand has subsequently come up with campaigns that are more in a humorous zone. Similarly, Gas-O-Fast has executed an influencer activity engaging with comedy content creators with an aim to raise brand awareness in a fun and quirky way. The comedy content creators that are part of the campaign are Neel, Shirin Sewani, RJ Karishma, Indrani Biswas, Avnish.

Adding to this, the brand for the very first time has collaborated with Food bloggers as well. The influencer videos showcase how they end up eating a lot due to their professional choices and usually face acidity, gas and indigestion. Keeping this in mind the brand aims to drive relevance via contextual conversations and position them as the number one choice to enjoy food without any hesitation. To convey the messaging, the brand has collaborated with food bloggers such as Sarah Hussain, Nisha Rajput and Srishti & Vaibhav

The food bloggers have a following of mainly food lovers and enthusiasts, who love exploring various cuisines, and through this collaboration, the brand aims to raise awareness about Gas-O-Fast as the solution for all the over-eating and its benefits for food lovers. The overall campaign highlights and positions Gas-O-Fast sachets as a true companion for every celebration.

Talking about the new campaign, Joy Chatterjee, General Manager, Sales & Marketing of Mankind Pharma said, “We are focused towards building and establishing Gas-O-Fast sachets as the trusted ally for acidity, gas and Indigestion. We are aggressive towards building and strengthening our presence in the market. We have been coming up with interesting campaigns and collaborations to raise brand awareness and ensure optimum market share for our brand in the antacid industry. Gas-O-Fast sachets give quick relief from acidity, gas and indigestion. It is available with Jeera and Ajwain variants.

Gas-O-Fast is an Ayurvedic antacid brand from Mankind Pharma house, one of the leading pharmaceutical companies in India. Mankind Pharma and brands work towards the efforts of Make in India and Vocal for Local ideology. Gas-O-Fast has Ayurvedic antacid properties and its range of products are – Jeera, Ajwain, Guava and Lemon.